An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation?: CCR6/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune disease.
about
Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overviewRegulation of atherogenesis by chemokine receptor CCR6Deoxynivalenol as a new factor in the persistence of intestinal inflammatory diseases: an emerging hypothesis through possible modulation of Th17-mediated responseCCR6 supports migration and differentiation of a subset of DN1 early thymocyte progenitors but is not required for thymic nTreg developmentExpression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial CellsLeukocyte attraction by CCL20 and its receptor CCR6 in humans and mice with pneumococcal meningitis.CCR6+ B lymphocytes responding to tumor cell-derived CCL20 support hepatocellular carcinoma progression via enhancing angiogenesisIL-17-producing γδ T cells switch migratory patterns between resting and activated states.Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation.CCL20/CCR6-mediated migration of regulatory T cells to the Helicobacter pylori-infected human gastric mucosa.Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages.An early reduction in Treg cells correlates with enhanced local inflammation in cutaneous leishmaniasis in CCR6-deficient mice.EBV infection is common in gingival epithelial cells of the periodontium and worsens during chronic periodontitisHelicobacter pylori infection reduces disease severity in an experimental model of multiple sclerosisLateral fluid percussion injury of the brain induces CCL20 inflammatory chemokine expression in rats.Chemokine Ligand 20: A Signal for Leukocyte Recruitment During Human Ovulation?CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cellsNew perspectives on central and peripheral immune responses to acute traumatic brain injury.Aryl Hydrocarbon Receptor Activation Synergistically Induces Lipopolysaccharide-Mediated Expression of Proinflammatory Chemokine (c-c motif) Ligand 20.Functional characterization of ferret CCL20 and CCR6 and identification of chemotactic inhibitors.Enhanced rho-associated protein kinase activation in patients with systemic lupus erythematosus.CC Chemokine Ligand 20 and Its Cognate Receptor CCR6 in Mucosal T Cell Immunology and Inflammatory Bowel Disease: Odd Couple or Axis of Evil?Distinct chemokine receptor axes regulate Th9 cell trafficking to allergic and autoimmune inflammatory sitesAnkylosing spondylitis: from cells to genesTh17 cells and Tregs: unlikely allies.Future perspectives: should Th17 cells be considered as a possible therapeutic target in acute myeloid leukemia patients receiving allogeneic stem cell transplantation?IL-1 signaling is critical for expansion but not generation of autoreactive GM-CSF+ Th17 cells.Monocyte/Macrophage: NK Cell Cooperation-Old Tools for New Functions.α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology.IRF6 Regulates the Expression of IL-36γ by Human Oral Epithelial Cells in Response to Porphyromonas gingivalis.CCR6+ Th cells in the cerebrospinal fluid of persons with multiple sclerosis are dominated by pathogenic non-classic Th1 cells and GM-CSF-only-secreting Th cells.Nonsegmental vitiligo and autoimmune mechanism.Expression patterns of chemokine receptors on circulating T cells from myelodysplastic syndrome patients.Helicobacter pylori-Mediated Protection against Extra-Gastric Immune and Inflammatory Disorders: The Evidence and Controversies.Mutation-Induced Functional Alterations of CCR6.Circulating CCL20 as a New Biomarker of Abdominal Aortic Aneurysm.Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3.Different gene response to mechanical loading during early and late phases of rat Achilles tendon healing.Expression of CCR6 in esophageal squamous cell carcinoma and its effects on epithelial-to-mesenchymal transition.Expression of Membrane-Bound CC Chemokine Ligand 20 on Follicular T Helper Cells in T-B-Cell Conjugates.
P2860
Q26774619-8FDADF51-B969-4D9A-B8B8-6FA2CCF0C424Q27023950-6DA42BED-5AF7-4463-9463-EE1B51180CF2Q27321054-26FDA7BA-E2AE-4521-BA3B-03BA9CF5C726Q28513341-29120F76-AE2E-41C1-9F82-FC1467FD8D7FQ28550697-B64037AA-6C24-4BDB-8C06-A592AC0450D4Q31156447-491535BE-69C0-43F1-A6E5-953E028B8FEFQ33733021-ACD29307-5E2A-403F-A3A2-46E083CFC1BEQ33780948-635F3337-771C-412A-A45E-15D4E089CED5Q34032559-38A8FB45-FED6-4F87-8FC3-36296DC66070Q34237268-14983766-F069-479F-8710-8DD424AB706CQ34263905-CA80A8B0-2099-4FC9-B578-6DAFC5D7393BQ34427121-636EC99C-F83E-46B1-B5B5-7A234F1F9B80Q35075193-90E9A312-55FA-4E65-8B0F-DFCDD634F1B1Q35082342-28F368AE-1975-4161-8F21-D102EA789EAEQ35595627-3F24A1B4-898D-4B8C-9C23-1EF2D014D786Q35970931-BB9E66B2-79E9-4A36-AAF9-CA5DAE29ADEDQ36266282-EA4AAB87-43F9-4E2E-95B4-D5878345A44DQ36478408-0FE2C33B-F7C9-4FC9-B0DF-9082D5D6DDCAQ36515917-CA402F69-B670-4430-B49A-3DBA67235172Q36677825-03537FA2-4695-4464-9F53-20EA0FC7B89DQ36901827-1E19AF63-420C-4905-9365-53CFCB45FB88Q37012341-D9E811C8-C256-498C-9126-8FE052D99148Q37039453-681A0E4B-EF78-400C-92B3-E11C760FA0F0Q37077734-ECB9BEEA-26F3-46EE-8549-BDEDB05BA403Q37700178-B1955850-7F27-4827-A51E-4AA496644168Q37944472-B08AB1F9-A2C0-4882-97F8-78D8D27F8FE4Q39202278-00012651-2B77-4882-9372-6B7A52E30F4CQ39271596-1178A348-83D5-4DFA-A178-F9B1D42D76F1Q39972820-EF375515-EFD9-48EC-891D-F2B8C9EE78F0Q40815050-EE5103A0-CAFE-4CD9-9AE0-29F69AA6B094Q41005423-9B137130-846E-4E47-92DC-1213ADC29759Q41954249-3C00E452-B244-4AA7-B04A-428060D85177Q42036124-3D25704B-EF6E-4C87-82FE-EDDF9B1DBDB5Q42343441-99FC0CA9-2254-4C8D-8ABC-DF1D5FD898B5Q42501097-05127AFC-ED2A-41EA-9E0C-D90B38001AA1Q47164996-E7698AF3-19B2-4410-9A24-BED5B5FA324DQ47719808-4A698B20-2A17-4B66-B6BF-F522B741EF81Q48129266-9B12739A-E8CB-467C-B20E-F6F6918DEBBEQ49168057-7784B860-BED8-454F-AFF2-6A8EACDC79AAQ49366827-09AAC2E9-5675-40E3-AEA8-502AA2721CC8
P2860
An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation?: CCR6/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An immune paradox: how can the ...... mmation in autoimmune disease.
@en
An immune paradox: how can the ...... mmation in autoimmune disease.
@nl
type
label
An immune paradox: how can the ...... mmation in autoimmune disease.
@en
An immune paradox: how can the ...... mmation in autoimmune disease.
@nl
prefLabel
An immune paradox: how can the ...... mmation in autoimmune disease.
@en
An immune paradox: how can the ...... mmation in autoimmune disease.
@nl
P2093
P2860
P356
P1433
P1476
An immune paradox: how can the ...... mmation in autoimmune disease.
@en
P2093
Carly Gregor
Ervin Kara
Iain Comerford
Julie Brazzatti
Kevin Fenix
Mark Bunting
Michelle Turvey
Phillip Nguyen
Sarah Haylock-Jacobs
Shaun R McColl
P2860
P304
P356
10.1002/BIES.201000063
P407
P577
2010-10-15T00:00:00Z